Close Menu
News Article

Texas Biomed joins TAMEST, state’s premier scientific academy

SAN ANTONIO (Feb. 3, 2025) — The Texas Academy of Medicine, Engineering, Science and Technology, better known as TAMEST, has named Texas Biomedical Research Institute (Texas Biomed) as a member institution.

At the state’s most prestigious scientific organization, membership includes all Texas-based members of the National Academies of Sciences, Engineering, and Medicine, and other honorary societies. TAMEST has more than 345 individual members, including the state’s eight Nobel Laureates. Texas Biomed joins as one of 24 member institutions.

“With your support, TAMEST will be able to strengthen Texas as a national leader in medicine, engineering, science and technology and help advance the next generation of scientists and researchers,” wrote TAMEST President Brendan Lee, M.D., Ph.D. in the letter inviting Texas Biomed to join.

This week, TAMEST will bring its members together to discuss disruptive breakthroughs in science and technology at its annual conference in Irving, Texas. Representing Texas Biomed there will be Professor, President and CEO Larry Schlesinger, M.D.; Professor and Interim Vice President for Research Shelley Cole, Ph.D.; Assistant Professor Olena Shtanko, Ph.D.; and Assistant Professor Victoria Baxter, Ph.D.

Dr. Larry Schlesinger

“We are honored to be a part of the TAMEST network and connect with brilliant scientific minds across the state,” said Dr. Schlesinger. “Only through collaboration and supporting our up-and-coming researchers will we be able to tackle the scientific challenges we all want to solve.”

TAMEST was founded in 2004 by then-U.S. Sen. Kay Bailey Hutchison and Nobel Laureates Michael S. Brown, M.D., and Richard E. Smalley, Ph.D. with the aim of fostering collaboration, innovation, research and business in Texas. Other member institutions include the state’s top public and private universities and Southwest Research Institute. 

About Texas Biomed

Texas Biomed is a nonprofit research institute dedicated to protecting the global community from infectious diseases. Through basic research, preclinical testing and innovative partnerships, we accelerate diagnostics, therapies and vaccines for the world’s deadliest pathogens. Our San Antonio campus hosts high containment laboratories and the Southwest National Primate Research Center. Our scientists collaborate with industry and researchers globally, and have helped deliver the first COVID-19 vaccine, the first Ebola treatment and first Hepatitis C therapy.